Mashup Score: 3 Maintenance Cabozantinib Following Chemotherapy for Metastatic Urothelial Carcinoma - 2 year(s) ago Interview with Guru Sonpavde MD Source: PracticeUpdate Categories: Hem/Oncs, Latest Headlines Tweet Tweets with this article sonpavde Maintenance Cabozantinib following platinum-based #chemotherapy for Metastatic #urothelialcarcinoma-no improvement of PFS (excluded HRD, AR altered tumors) #ASCO22 @CR_UK-#MAINCAV-maintenance avelumab +/- cabo phase III ongoing @shilpaonc https://t.co/CzVNYUVNCz @practiceupdate
Maintenance Cabozantinib following platinum-based #chemotherapy for Metastatic #urothelialcarcinoma-no improvement of PFS (excluded HRD, AR altered tumors) #ASCO22 @CR_UK-#MAINCAV-maintenance avelumab +/- cabo phase III ongoing @shilpaonc https://t.co/CzVNYUVNCz @practiceupdate